Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on January 1, 2007

Published online before print October 23, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0306196v1
81/1/67    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urbonaviciute, V.
Right arrow Articles by Voll, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urbonaviciute, V.
Right arrow Articles by Voll, R. E.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0306196

Received for publication April 21, 2006.
Revised September 1, 2006.
Accepted for publication September 4, 2006.

Article

Factors masking HMGB1 in human serum and plasma

Vilma Urbonaviciute *, Barbara G. Fürnrohr *, Christian Weber *, Martin Haslbeck {dagger}, Sabine Wilhelm *, Martin Herrmann {ddagger}, and Reinhard E. Voll *{ddagger}@

*IZKF Research Group 2, Nikolaus-Fiebiger-Center of Molecular Medicine, University of Erlangen-Nürnberg, Germany; {dagger}Department Chemistry, Technical University Munich, Germany; and {ddagger}Department of Internal Medicine 3, University Hospital Erlangen, Germany

@ To whom correspondence should be addressed. E-mail: rvoll{at}molmed.uni-erlangen.de.


  Abstract

High mobility group box 1 protein (HMGB1) is a ubiquitously expressed architectural chromosomal protein. Recently, it has become obvious that HMGB1 can also act as a proinflammatory mediator when actively secreted during cell activation or passively released from necrotic cells. HMGB1 appears to play an important role in the pathogenesis of diseases, including sepsis and rheumatoid arthritis. However, easy, sensitive, and reliable detection systems are required to investigate the clinical significance of HMGB1 in clinical samples for diagnosis and prognosis of diseases. Here, we describe sensitive ELISAs for the detection of HMGB1 in cell culture medium and cell lysates. However, these assays failed to reliably quantitate HMGB1 in serum and plasma when compared with immunoblot analysis. We found that serum/plasma components bind to HMGB1 and interfere with its detection by ELISA systems. In most serum/plasma samples investigated, including those from healthy individuals, we detected IgG antibodies binding to HMGB1. The titers of these antibodies correlated with the capacity of sera to interfere with the detection of recombinant HMGB1 by ELISA. Furthermore, HMGB1 coimmunoprecipitated with several proteins including IgG1, as identified by mass spectrometry. These HMGB1 interacting proteins are currently characterized and may contribute to complex formation, masking, and possibly, modulation of cytokine activity of HMGB1.

Key Words: autoantibodies • ELISA • systemic lupus erythematosus • rheumatoid arthritis




This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. M. Alleva, A. C. Budd, and I. A. Clark
Systemic Release of High Mobility Group Box 1 Protein during Severe Murine Influenza
J. Immunol., July 15, 2008; 181(2): 1454 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. E. Bianchi
DAMPs, PAMPs and alarmins: all we need to know about danger
J. Leukoc. Biol., January 1, 2007; 81(1): 1 - 5.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.